AI Article Synopsis
- The study examined the expressed emotion (EE) status of relatives of patients with first-episode and chronic schizophrenia and depression, focusing on whether there were significant differences between these groups.
- Both groups showed similar levels of high EE, with 52.5% for first-episode and 45% for chronic patients, indicating that family emotional involvement does not vary significantly with the stage of illness.
- Additionally, the EE indices for relatives of those with schizophrenia were comparable to those of depressed patients, suggesting that high EE is not specific to any particular disorder or illness progression.
Article Abstract
Relatives of first-episode and chronic schizophrenic and depressed patients were examined with respect to their expressed emotion (EE) status. The two aims of the study were to (1) investigate whether relatives of first-episode patients differed from family members of chronic patients, and (2) whether EE indices of relatives of schizophrenic patients were comparable to those of depressed subjects. Twenty patients of each diagnostic group (DSM-III-R and DSM-IV) were included, i.e. a total of 80 patients. The EE status of key relatives was assessed with the Five-Minute Speech Sample on the basis of critical comments and emotional overinvolvement. Additionally, the new criterion 'covert criticism' was applied to detect indirect expressions of critique. Relatives of first-episode and chronic patients of both diagnostic groups did not differ significantly regarding their EE status; in first-episode patients, 52.5% of relatives were classified high EE; in chronic patients, 45%. Moreover, EE indices of relatives of schizophrenic and depressed patients were comparable. Analysis revealed 52.5 and 45% high-EE relatives in the depression and the schizophrenia subsamples, respectively. Thus, the overall incidence of high-EE relatives was comparable to numbers reported in the literature. In our study EE status of relatives was not disease-specific, and it was independent of chronicity of illness.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0165-1781(02)00226-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute pyelonephritis in adults. Should we adopt the pediatric guidelines?
Urologia
December 2024
Department of Urology & Pediatric Urology, Shaare Zedek Medical Center, Faculty of Medical Science, Hebrew University, Jerusalem, Israel.
Purpose: There are no guidelines, what recommend pro or against cystography for identification of VUR for adults who suffer from first episode of pyelonephritis. The aim of this study was to look at incidence of VUR in adults with first episode of pyelonephritis, and to highlight recommendations for possible reflux investigation in these patients.
Methods: We have performed retrospective review of all patients who admitted at our department over the last decade with the working diagnosis of acute pyelonephritis.
Mental health during the 2022 Russo-Ukrainian War: A scoping review and unmet needs.
J Affect Disord
December 2024
Department of Neuroscience, Reproductive Science and Dentistry, Section of Psychiatry, Federico II University of Naples, Italy; Staff UNESCO - Chair for Health Education and Sustainable Development at Federico II University of Naples, Naples, Italy.
Introduction: The Russo-Ukrainian War (RUW) poses a significant mental health burden, warranting a scoping review of the evidence to shed light on the unmet needs.
Methods: MEDLINE/PubMed and EMBASE databases were inquired from inception until September 1st, 2023, to address the following a-priori-formulated questions: i) "Which psychiatric population has been assessed? How did the conflict affect the functioning of people with established mental health conditions (e.g.
Indigenous-non-Indigenous disparities in health and social outcomes 5 years after first episode psychosis: national cohort study.
BJPsych Open
December 2024
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
Background: There are ethnic differences, including differences related to indigeneity, in the incidence of first episode psychosis (FEP) and pathways into care, but research on ethnic disparities in outcomes following FEP is limited.
Aims: In this study we examined social and health outcomes following FEP diagnosis for a cohort of Māori (Indigenous people of New Zealand) and non-Māori (non-Indigenous) young people. We have focused on understanding the opportunities for better outcomes for Māori by examining the relative advantage of non-Māori with FEP.
Meta-Analysis of the Efficacy of Risperidone Treatment in Patients with First-Episode Schizophrenia.
Noro Psikiyatr Ars
November 2024
Department of nursing, The First Affiliated Hospital of Hainan Medical College, Hai-kou, China.
Article Synopsis
- First-episode schizophrenia is common and complex, necessitating an evaluation of the treatment effectiveness of risperidone through a meta-analysis of existing studies.
- A total of 15 studies were assessed, showing that risperidone significantly improves cure rates and overall improvement compared to control groups.
- While risperidone is effective, it may cause side effects like weight gain and extrapyramidal symptoms, which need to be considered in treatment plans.
Insulin resistance links dysbiosis of gut microbiota with cognitive impairment in first-episode drug-naïve schizophrenia.
Psychoneuroendocrinology
December 2024
Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Henan International Joint Laboratory of Biological Psychiatry, Zhengzhou, China; Henan Psychiatric Transformation Research Key Laboratory, Zhengzhou University, Zhengzhou, China. Electronic address:
This study aimed to explore the relationship among gut microbiota imbalance, the homeostasis model of assessment of insulin resistance (HOMA-IR) and cognitive impairments in patients with schizophrenia (SCZ). We conducted a case-control study involving 189 first-episode, drug-naïve SCZ patients and 115 healthy controls (HCs). Main methods adopted included metagenomics analysis, glucose metabolism assessment, and cognitive function evaluation using the MATRICS Consensus Cognitive Battery (MCCB).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!